New 4-aminobicyclo[2.2.2]octane derivatives and their activities against <em>Plasmodium falciparum</em> and <em>Trypanosoma b. rhodesiense</em> (Publications)
A series of new 2-substituted 4-dialkylaminobicyclo[2.2.2]octane derivatives was prepared and the compounds were investigated for their activity against causative organisms of tropical diseases. The t
Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use (Publications)
The Swiss Registry for Cystic Fibrosis (SRCF) was designed to collect demographic, clinical and therapeutic data from patients with cystic fibrosis (CF) in Switzerland. It was designed, programmed and
Vaccines for enteric diseases: update on recent developments (Publications)
The 5th International Conference on Vaccines for Enteric Diseases (VED) attracted more than 250 delegates, mainly from industrialized countries. A total of 56 papers were presented and 46 posters were
Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness (Publications)
In 2000, we reported that a new short treatment schedule of melarsoprol was not worse than the longer and demanding standard treatment for late-stage human African trypanosomiasis. This alternative sc
The health relevance of ambient particulate matter characteristics: coherence of toxicological and epidemiological inferences (Publications)
The aim of this article is to review progress toward integration of toxicological and epidemiological research results concerning the role of specific physicochemical properties, and associated source
Combined evoked potentials as markers and predictors of disability in early multiple sclerosis (Publications)
OBJECTIVE: To prospectively assess combined evoked potentials (EP) as markers and predictors of the disease course of early MS over 3years. METHODS: Fifty patients in the early phase of relapsing remi